Results 51 to 60 of about 2,542 (110)
Massive circulating metastatic cells: A case of carcinocythemia
Key Clinical Message Importance of careful differential diagnosis to make the distinction between carcinocythemia and acute leukemia or lymphoma.
Carine Farkh +3 more
doaj +1 more source
Evading immune eradication is a prerequisite for neoplastic progression and one of the hallmarks of cancer. Here, we review the different immune escape strategies of lymphoma and classify them into two main mechanisms. First, lymphoma cells may “hide” to
Marie de Charette, Roch Houot
doaj +1 more source
Exploring the needs and resources of children in a haematology-oncology unit
Too often a child’s body is restored to health in the hospital, but the child is sent home with emotional wounds. This study explored the needs of children in a haematology-oncology unit as well as the resources that could be mobilised in order to ...
Annemarie E. Oberholzer +3 more
doaj +1 more source
Despite the high efficiency of tyrosine kinase inhibitors (TKI), some patients with chronic myeloid leukemia (CML) will display residual disease that can become resistant to treatment, indicating intraclonal heterogeneity in chronic‐phase CML (CP‐CML ...
Stéphanie Maupetit‐Mehouas +14 more
doaj +1 more source
Posterior reversible encephalopathy syndrome (PRES) and myeloma
Posterior reversible encephalopathy syndrome (PRES) has rarely been described in myeloma, but chemotherapy is a known risk factor. We report 3 patients with myeloma who developed PRES, and analyzed them with 13 published cases, mostly women.
Ricardos Ghanem +7 more
doaj +1 more source
INTRODUCTION: Le taux de lymphocytes T-CD4 (LT4) est un paramètre crucial de suivi et de décision thérapeutique au cours de l'infection au Virus de l'Immunodéficience Humaine (VIH). Sa détermination doit être fiable et précise. Pour fournir des résultats
Koffi N’guessan +4 more
doaj +1 more source
In chronic myeloid leukemia, the identification of early molecular predictors of stable treatment-free remission (TFR) after tyrosine kinase inhibitor (TKI) discontinuation is challenging.
Sandrine Saugues +14 more
doaj +1 more source
Key Clinical Message A 71‐year‐old female patient with no major history of infection had presented with recurrent chronic purulent sinusitis over the past 3 years.
Gérard Dine +3 more
doaj +1 more source

